While there was a clear pattern of CD4 T cell decline in un-treated mice, their levels were stable in both groups of mice receiving raltegravir or maraviroc further confirming the absence of HIV-1 infection in these mice (Fig. 4). The gene discussed is CD4; the disease is HIV-1 infection.